Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
Basic
4
Ṁ1052026
38%
chance
1D
1W
1M
ALL
This category of drug is finding more and more uses for a variety of conditions, but the history of drugs, and weight loss drugs in particular, is legally fraught (Phen-Fen, etc.) Are we irrationally exuberant about GLP1 or is it different this time?
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
What will happen to the GLP-1 / Ozempic compounding pharmacy loophole?
Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by 01/01/2025?
7% chance
Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
75% chance
Reliable Reporting indicating that more than 3% of Americans are taking GLP-1 agonists in 2024
36% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
30% chance
Will there be any $1 billion lawsuits in the USA in 2024?
70% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Will Lantern Biotech get sued for over $1M by 2029?
32% chance
What fraction of US adults will regularly take GLP-1 drugs in 2030?